Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer
Completed · Phase 3 · Has a placebo group
Conditions studied: Breast Neoplasms
In brief
This study evaluated and compared the efficacy and tolerability of lapatinib and letrozole, with letrozole and placebo in post-menopausal women with hormone receptor positive (ER positive and/or PgR positive) advanced or metastatic breast cancer, who had not received prior therapy for advanced or metastatic disease.
Key facts
- Study ID
- NCT00073528
- Run by
- Novartis Pharmaceuticals
- People needed
- 1286
- Starts
- 2003-12-09
- Expected to finish
- 2018-03-22
- Last updated by the study team
- 2021-02-24
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Novartis Investigative Site — Hot Springs, Arkansas, United States
- Novartis Investigative Site — Jonesboro, Arkansas, United States
- Novartis Investigative Site — Alhambra, California, United States
- Novartis Investigative Site — Bakersfield, California, United States
- Novartis Investigative Site — Duarte, California, United States
- Novartis Investigative Site — Fountain Valley, California, United States
- Novartis Investigative Site — Fresno, California, United States
- Novartis Investigative Site — Fullerton, California, United States
- Novartis Investigative Site — La Jolla, California, United States
- Novartis Investigative Site — Long Beach, California, United States
- Novartis Investigative Site — Los Angeles, California, United States
- Novartis Investigative Site — Montebello, California, United States
- Novartis Investigative Site — Northridge, California, United States
- Novartis Investigative Site — Oxnard, California, United States
- Novartis Investigative Site — Pleasant Hill, California, United States
- Novartis Investigative Site — Porterville, California, United States
- Novartis Investigative Site — Redondo Beach, California, United States
- Novartis Investigative Site — San Diego, California, United States
- Novartis Investigative Site — Santa Barbara, California, United States
- Novartis Investigative Site — Santa Maria, California, United States
- Novartis Investigative Site — Vallejo, California, United States
- Novartis Investigative Site — Vista, California, United States
- Novartis Investigative Site — Aurora, Colorado, United States
- Novartis Investigative Site — Denver, Colorado, United States
- Novartis Investigative Site — Tucson, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.